Arcam AB fka AMAVF

[mauser96]

tinker those are some cogent questions.
Looking at it from the long term the questions about all that EU free (to Arcam) research getting into real world products is the most important one. Because if they can make their machines 5 times better, which management has said was "easy" it should be pretty obvious that they will sell more machines

I have been using the figure of "8 years from lab to fab" from general observations but have no idea whether it really applies to Arcam. Fastebm is only the first of several research projects. I also make the assumption that much (most?) of the research will not work out in mass production.

Because if EBM machines are on the verge of getting even 2 or 3 times faster/cheaper/more reliable/more accurate (take your choice) this is a real inflection point. Because they are making money even with present machines.